No-Touch spray could ease shingles nerve pain

NCT ID NCT07599800

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a lidocaine spray (APC101) for people with postherpetic neuralgia, a painful nerve condition after shingles. The spray delivers pain relief without touching the sensitive skin. About 333 adults will use the spray or a placebo to see if it reduces pain over 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Lidocaine spray 5% solution

What this could lead to

If it works, this could provide a convenient, gentle way to manage nerve pain after shingles without touching the painful skin.

What could go wrong

This is an early-to-mid stage trial, so the spray may not prove more effective than a placebo. Also, lidocaine can cause skin irritation or allergic reactions in some people.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHN - POST-HERPETIC NEURITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

postherpetic neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Suncoast Clinical Research

    Florida City, Florida, 34652, United States

  • University of Sunshine Cost

    Brisbane, Queensland, 4117, Australia